Organon & Co. (OGN)
9.405
-0.36
(-3.64%)
USD |
NYSE |
Apr 20, 12:03
Organon Total Assets (Quarterly) : 12.87B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 136.87B |
| Abbott Laboratories | -- |
| Gilead Sciences, Inc. | 59.02B |
| Pfizer Inc. | 208.16B |
| Replimune Group, Inc. | 333.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.12B |
| Shareholders Equity (Quarterly) | 752.00M |
| Debt to Equity Ratio | 11.70 |
| Current Ratio | 1.821 |
| Net Debt Paydown Yield | -0.55% |